During the past decade, Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid" are "Physical Disability" (2 trials), "Cardiovascular Disease" (1 trials), "Cardiovascular Risk Factors" (1 trials) and "Cognitive Dysfunction" (1 trials). Many other conditions were trialed in "Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid" in a lesser frequency.

The vast majority of trials in "Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".